Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.4K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.4K
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

1.3K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.3K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

206
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
206
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

310
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
310
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.5K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

282
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
282

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case series.

Antimicrobial agents and chemotherapy·2025
Same author

Study Design and Rationale for The Breathe Easier With Tadalafil Therapy for Exercise-Related Dyspnea in COPD-PH (BETTER COPD-PH).

Pulmonary circulation·2025
Same author

Optimising the impact of smartphone-activated volunteer responder programs on out-of-hospital cardiac arrest outcomes by increasing responder density.

The Medical journal of Australia·2025
Same author

Evaluation of the Effectiveness of Advanced Technology Clinical Simulation Manikins in Improving the Capability of Australian Paramedics to Deliver High-Quality Cardiopulmonary Resuscitation: Pre- and Postintervention Study.

JMIR cardio·2024
Same author

Attitudes towards and engagement in self-directed learning among paramedics in New South Wales, Australia: a cross sectional study.

BMC medical education·2023
Same author

Reference Range of Hydroxychloroquine Blood Levels That Can Reduce Odds of Active Lupus and Prevent Flares.

Arthritis care & research·2023

Related Experiment Video

Updated: Feb 20, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.3K

The Adherence Rate Threshold is Drug Specific.

Melissa E Stauffer1, Paul Hutson2, Anna S Kaufman3

  • 1ScribCo, Effort, PA, USA. melstauff@charter.net.

Drugs in R&D
|October 28, 2017
PubMed
Summary

The common 0.8 adherence rate threshold is not universally applicable for statins. Objective analysis shows simvastatin requires higher adherence than atorvastatin to maintain therapeutic cholesterol levels.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.7K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.0K

Related Experiment Videos

Last Updated: Feb 20, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.3K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.7K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.0K

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine
  • Health Outcomes Research

Background:

  • Patient medication adherence is crucial for therapeutic efficacy.
  • Adherence rates are typically assessed using an arbitrary threshold, commonly set at 0.8.
  • The universal applicability of this threshold across different medications is questionable.

Purpose of the Study:

  • To objectively determine the adherence rate threshold for maintaining therapeutic low-density lipoprotein cholesterol (LDL-C) goals.
  • To compare these thresholds for two different statin medications: simvastatin and atorvastatin.

Main Methods:

  • Pharmacokinetic/pharmacodynamic (PK/PD) modeling was employed.
  • Simulations predicted serum LDL-C levels for various adherence rates (1.0, 0.8, 0.6, 0.4, 0.2).
  • The adherence threshold was defined as the minimum rate achieving the same time at LDL-C goal (<70 mg/dL) as perfect adherence (1.0).

Main Results:

  • Simvastatin showed a significant decrease in time at LDL-C goal with an adherence rate of 0.8 (54.8%) compared to perfect adherence (85.1%).
  • Atorvastatin maintained similar time at LDL-C goal with adherence rates of 0.8 (87.8%) and 0.6 (87.7%) versus perfect adherence (88.1%).
  • Adherence rate thresholds were determined to be >0.8 for simvastatin and between 0.4-0.6 for atorvastatin.

Conclusions:

  • The adherence rate threshold of 0.8 is not universally applicable for all statins.
  • Objective determination of adherence thresholds is essential for personalized medication management.
  • Statin type influences the required adherence rate for achieving therapeutic goals.